Literature DB >> 32339231

Epidemiological Characteristics and Incubation Period of 7015 Confirmed Cases With Coronavirus Disease 2019 Outside Hubei Province in China.

Xiuquan Nie1,2, Lieyang Fan1,2, Ge Mu1,2, Qiyou Tan1,2, Mengyi Wang1,2, Yujia Xie1,2, Limin Cao1,2, Min Zhou1,2, Zhuang Zhang1,2, Weihong Chen1,2.   

Abstract

BACKGROUND: Disease caused by SARS-CoV-2 broke out in Wuhan in December 2019. We utilized confirmed cases outside Hubei Province to analyze epidemiologic characteristics and evaluate the effect of traffic restrictions implemented in Hubei beginning on 23 January 2020.
METHODS: Information on 7015 confirmed cases from 19 January to 8 February 2020 in all provinces outside Hubei was collected from the national and local health commissions in China. Incubation period and interval times were calculated using dates of the following events: contact with an infected person, onset, first visit, and diagnosis. We evaluated changes in incubation period and interval times.
RESULTS: The average age of all cases was 44.24 years. The median incubation period was 5 days and extended from 2 days on 23 January to 15 days on 8 February. The proportion of imported cases decreased from 85.71% to 33.19% after 23 January. In addition, lengths of intervals between onset and diagnosis, onset and first visit, and first visit and diagnosis decreased over time.
CONCLUSIONS: Rapidly transmitting COVID-19 has a short incubation period. The onset mainly occurred among young to middle-aged adults. Traffic restrictions played an important role in the decreased number of imported cases outside Hubei.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  SARS-CoV-2; coronavirus disease 2019; incubation period

Mesh:

Year:  2020        PMID: 32339231      PMCID: PMC7197553          DOI: 10.1093/infdis/jiaa211

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Community movement and COVID-19: a global study using Google's Community Mobility Reports.

Authors:  M Sulyok; M Walker
Journal:  Epidemiol Infect       Date:  2020-11-13       Impact factor: 2.451

2.  Increasing Age, the Existence of Comorbidities, and Corticosteroid Treatment in Combination With Antiviral Therapy Prolongs the Recovery of SARS-COV-2-Infected Patients, Measured as the Conversion From Positive to Negative rtPCR: A 239 Patients' Retrospective Study.

Authors:  Sheng Zhu; Yaxiong Huang; Wei Tang; Andreas K Nussler; Fang Zheng
Journal:  Front Med (Lausanne)       Date:  2020-11-12

3.  Epidemiological Characteristics and Factors Associated with Critical Time Intervals of COVID-19 in Eighteen Provinces, China: A Retrospective Study.

Authors:  Feng Zhou; Chong You; Xiaoyu Zhang; Kaihuan Qian; Yan Hou; Yanhui Gao; Xiao-Hua Zhou
Journal:  Int J Infect Dis       Date:  2020-10-09       Impact factor: 3.623

4.  Cutaneous Vesicular of COVID-19 in Two Burn Patients.

Authors:  Abdolkhalegh Keshavarzi; Ali Akbar Mohammadi; Mehdi Ayaz; Fatemeh Javanmardi; Mohammad Ali Hoghoughi; Babak Shirazi Yeganeh; Amir Emami; Mandana Mackie; Rahimeh Akrami; Sorayya Iranpak
Journal:  World J Plast Surg       Date:  2020-09

5.  COVID-19 Encephalopathy in Adults.

Authors:  Paavani Atluri; Deepa Vasireddy; Srikrishna Malayala
Journal:  Cureus       Date:  2021-02-01

6.  The differential demographic pattern of coronavirus disease 2019 fatality outside Hubei and from six hospitals in Hubei, China: a descriptive analysis.

Authors:  Qing-Bin Lu; Hai-Yang Zhang; Tian-Le Che; Han Zhao; Xi Chen; Rui Li; Wan-Li Jiang; Hao-Long Zeng; Xiao-Ai Zhang; Hui Long; Qiang Wang; Ming-Qing Wu; Michael P Ward; Yue Chen; Zhi-Jie Zhang; Yang Yang; Li-Qun Fang; Wei Liu
Journal:  BMC Infect Dis       Date:  2021-05-26       Impact factor: 3.090

7.  Minimizing transmission of COVID-19 while delivering optimal cancer care in a National Cancer Centre.

Authors:  Jianbang Chiang; Valerie Shiwen Yang; Shuting Han; Qingyuan Zhuang; Gideon Ooi; Iris Huili Sin; Gail Wan Ying Chua; Si Ying Tan; Claramae Shulyn Chia; Veronique Kiak-Mien Tan; Patricia Soek Hui Neo; Jin Wei Kwek; Swee Peng Yap; Ravindran Kanesvaran; Soon Thye Lim; William Ying Khee Hwang; Chee Kian Tham
Journal:  J Cancer Policy       Date:  2020-07-09

8.  Risk Factors for Death Among the First 80 543 Coronavirus Disease 2019 (COVID-19) Cases in China: Relationships Between Age, Underlying Disease, Case Severity, and Region.

Authors:  Yanping Zhang; Wei Luo; Qun Li; Xijie Wang; Jin Chen; Qinfeng Song; Hong Tu; Ruiqi Ren; Chao Li; Dan Li; Jing Zhao; Jennifer M McGoogan; Duo Shan; Bing Li; Jingxue Zhang; Yanhui Dong; Yu Jin; Shuai Mao; Menbao Qian; Chao Lv; Huihui Zhu; Limin Wang; Lin Xiao; Juan Xu; Dapeng Yin; Lei Zhou; Zhongjie Li; Guoqing Shi; Xiaoping Dong; Xuhua Guan; George F Gao; Zunyou Wu; Zijian Feng
Journal:  Clin Infect Dis       Date:  2022-03-01       Impact factor: 9.079

Review 9.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review.

Authors:  Wei Feng; Wei Zong; Feng Wang; Shaoqing Ju
Journal:  Mol Cancer       Date:  2020-06-02       Impact factor: 41.444

10.  Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset.

Authors:  Elie Azoulay; Muriel Fartoukh; Michael Darmon; Guillaume Géri; Guillaume Voiriot; Thibault Dupont; Lara Zafrani; Lola Girodias; Vincent Labbé; Martin Dres; Alexandra Beurton; Antoine Vieillard-Baron; Alexandre Demoule
Journal:  Intensive Care Med       Date:  2020-08-11       Impact factor: 41.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.